The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

However, steatosis can progress to nonalcoholic steatohepatitis ... with a liver biopsy being used when these less invasive tests are inconclusive. Summary and Conclusion Non-alcoholic fatty ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH) is a disease that occurs when steatosis (a buildup of fat) in the liver causes liver inflammation and damage.

Understanding liver fibrosis progression through machine learning provides valuable insights into disease mechanisms, ...

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen research ...

The tool, called AIM-NASH (Artificial Intelligence-Based Measurement of Non-alcoholic Steatohepatitis Histology) from Boston-based Path AI, supports pathologists in analyzing liver biopsy scans to ...